Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biomet, a designer, manufacturer and marketer of products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy, has reported a net loss of $478.7 million for the third quarter ended February 28, 2009, compared to a net loss of $88.5 million for the third quarter ended February 29, 2008.
Subscribe to our email newsletter
The company reported net sales of $615 million for the three months ended February 28, 2009, an increase of 2%, compared to $603.1 million for the three months ended February 29, 2008.
For the nine months ended February 28, 2009, the company reported a net loss of $578.3 million, compared to a net loss, as reported, of $927.3 million for the nine months ended February 29, 2008. The company reported net sales of $1.86 billion for the nine months ended February 28, 2009, compared to $1.49 billion for the period from July 12, 2007 to February 29, 2008.
Jeffrey Binder, Biomet’s president and CEO, said: “While the impact of the general economy on our dental implant business is resulting in a write-down of goodwill and intangible assets associated with the merger, I have confidence in the long-term attractiveness of the dental reconstructive market and Biomet 3i’s competitiveness in that market.”